在患有非糖尿病慢性病的患者中使用芬二 - - 一项回顾性研究
Rehab B Albakr1, Fadel AlRowaie2,3, Ibrahim A Sandokji4
1Department of Medicine, Division of Nephrology, College of Medicine, King Saud University, Riyadh 11472, Saudi Arabia.
Biomedicines
|October 29, 2025
概括
在非糖尿病慢性病 (CKD) 患者中,芬瑞有效降低了白蛋白尿和血压. 这项研究没有发现显著的不良影响,这表明对CKD管理的潜在益处.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 关于非糖尿病慢性病 (CKD) 患者的芬瑞的疗效和安全性的数据有限,特别是关于种族多样性的数据.
- 标准疗法通常包括氨酸- ангиотензин- алдостерон系统抑制剂和SGLT2抑制剂.
研究的目的:
- 为了评估finerenone对非糖尿病慢性病患者的白蛋白尿,功能和血压的影响.
- 为了调查与芬瑞治疗相关的高血和低血压等不良影响.
主要方法:
- 在沙特阿拉伯的利雅得国王法哈德医疗城进行了回顾性,单中心的探索性研究.
- 评估尿白蛋白与肌素比率 (UACR) 的变化和估计的淋巴细胞过率 (eGFR) 在finerenone启动后的变化.
- 使用威尔科克森签名等级测试进行统计分析 (p < 0.05).
主要成果:
- 包括16名非糖尿病CKD患者 (平均年龄38.5岁,56.3%男性).
- 专尿显著降低 (UACR从90.0降至39.3毫克/克,p=0.04) 和血压观察到.
- 没有报告过高血或低血压的病例.
结论:
- 费内伦在非糖尿病慢性结核病患者中显示出降低白蛋白尿和血压的潜力.
- 治疗显示出良好的安全性,没有显著的不良事件.
- 需要进一步的研究来证实这些有前途的研究结果对于非糖尿病性CKD管理.
相关概念视频
Renal Failure: Dose Adjustments
429
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
429
Factors Affecting Renal Clearance: Renal Impairment
415
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
415
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
232
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
232
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
185
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
185
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
205
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
205
Acute Kidney Injury IV: Diagnostic Studies and Prevention
256
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
256


